Glycogen Metabolism

Glycogen Metabolism

4 min read Updated Apr 18, 2026

Glycogen is the animal storage form of glucose - highly branched alpha-1,4 + alpha-1,6 polymer found in liver (for blood glucose buffering) and muscle (for local energy). Building it up and breaking it down are separate pathways, reciprocally regulated.

Glycogen: storing and releasing glucose

Pathway map
Storing · after a meal Releasing · between meals Glucose-6-P phosphoglucomutase Glucose-1-P UDP-glucose UTP glycogen synthase builds α-1,4 chains · rate-limiting GLYCOGEN liver ~100 g · muscle ~400 g branching enzyme adds α-1,6 branches every ~10 residues GLYCOGEN the same molecule glycogen phosphorylase cleaves α-1,4 · rate-limiting uses Pi, not water, so no ATP is spent debranching enzyme clears each α-1,6 branch point Glucose-6-P again LIVER has glucose-6-phosphatase releases free glucose into the blood MUSCLE no glucose-6-phosphatase keeps it and burns it locally One switch insulin → phosphatase → synthase ON, phosphorylase OFF glucagon and adrenaline → cAMP → PKA → exactly the reverse
1

Scroll sideways to see the whole map.

Storing (glycogen synthase) Releasing (glycogen phosphorylase) Junction metabolite Hormone signal
Glycogen is glucose kept in a form that costs nothing osmotically. Free glucose at the same concentration would pull enough water into the cell to burst it. The price is one UTP per residue stored, and a branch point that needs a separate enzyme to take apart.

Glycogen metabolism is a short detour off of glycolysis. When the cell has excess glucose-6-phosphate (the first glycolysis intermediate), it can store it as glycogen rather than running it through glycolysis. When energy is needed later, glycogen is broken down back to glucose-6-phosphate, which can then re-enter glycolysis (in muscle) or be released as blood glucose after G6Pase action (in liver). So glycogen is a short-term reserve that feeds back into the glycolysis → TCA → ETC pipeline when the cell needs it.

Glycogenesis (Building)

  1. Glucose-6-P → glucose-1-P (phosphoglucomutase).
  2. G1P + UTP → UDP-glucose + PPi (UDP-glucose pyrophosphorylase). UDP-glucose is the activated donor.
  3. Glycogen synthase adds UDP-glucose to the non-reducing end of a growing glycogen chain via alpha-1,4 linkage. Rate-limiting enzyme of glycogenesis.
  4. When the chain is ~11 residues long, branching enzyme transfers a short segment to an internal position via an alpha-1,6 bond, creating a branch.

Glycogenolysis (Breaking Down)

  1. Glycogen phosphorylase cleaves glucose-1-P from the non-reducing end of a branch using inorganic phosphate (Pi). Rate-limiting enzyme. Uses pyridoxal phosphate (PLP, vitamin B6) as a cofactor.
  2. When phosphorylase reaches 4 residues from a branch point, it stops.
  3. Debranching enzyme (a dual-function enzyme) moves three residues to the main chain (transferase activity) and then hydrolyzes the remaining alpha-1,6 glucose (glucosidase activity), releasing a free glucose.
  4. G1P → G6P (phosphoglucomutase). In liver, glucose-6-phosphatase converts G6P → free glucose, which leaves the cell. In muscle, G6P enters glycolysis for local ATP.

Hormonal Regulation

Insulin (fed state):

  • Dephosphorylates glycogen synthase → ACTIVE → storage.
  • Dephosphorylates glycogen phosphorylase → INACTIVE → no breakdown.

Glucagon (fasted) and epinephrine (stress):

  • Phosphorylates glycogen synthase → INACTIVE → no storage.
  • Phosphorylates glycogen phosphorylase kinase → phosphorylates glycogen phosphorylase → ACTIVE → breakdown.

Both hormones work through cAMP/PKA cascades that phosphorylate multiple targets simultaneously.

Glycogen Storage Diseases

Mutations in glycogen enzymes cause characteristic storage diseases:

| Disease | Deficient enzyme | Main findings |
|---------|-------------------|---------------|
| Von Gierke (type I) | Glucose-6-phosphatase | Severe fasting hypoglycemia, hepatomegaly |
| Pompe (type II) | Lysosomal alpha-glucosidase | Cardiomegaly, muscle weakness |
| Cori (type III) | Debranching enzyme | Mild hypoglycemia, short outer branches |
| McArdle (type V) | Muscle glycogen phosphorylase | Exercise intolerance, muscle cramps |

What enzyme is rate-limiting for glycogen synthesis vs. breakdown?
Click to reveal answer
Glycogen synthase is rate-limiting for synthesis (glycogenesis). Glycogen phosphorylase is rate-limiting for breakdown (glycogenolysis). Both are reciprocally controlled by phosphorylation: glucagon/epinephrine activate the PKA cascade, which phosphorylates and ACTIVATES phosphorylase while INACTIVATING synthase. Insulin reverses both.
What are the two activities of debranching enzyme?
Click to reveal answer
Debranching enzyme is bifunctional. It has a transferase activity that moves a short segment (usually three alpha-1,4-linked glucoses) from a branch to the main chain, and a glucosidase (alpha-1,6-glucosidase) activity that hydrolyzes the remaining single alpha-1,6-linked glucose, releasing it as free glucose. Both activities are needed to fully degrade glycogen.
Why does Von Gierke disease produce more severe hypoglycemia than McArdle disease?
Click to reveal answer
Von Gierke is a defect in glucose-6-phosphatase, which is required for BOTH glycogenolysis and gluconeogenesis to produce free blood glucose. Neither pathway can deliver glucose. McArdle is a muscle-specific glycogen phosphorylase defect; the liver (a separate isozyme) is unaffected, so blood glucose can still be maintained. McArdle causes exercise intolerance but not systemic hypoglycemia.